Live News Categoriesmarket

TNGX.O (TNGX.O) News

Follow TNGX.O (TNGX.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol TNGX.O Asset market Sector Markets 90 days 1 Updated Oct 16, 2026, 11:03 AM UTC Open live news feed

H Tango Therapeutics to Present Updated Vopimetostat Combination Trial Data at ESMO 2026 Tango Therapeutics will present updated Phase 1/2 vopimetostat combination data at the ESMO Congress in Madrid on Oct. 25, 2026. The study evaluates vopimetostat with daraxonrasib or zoldonrasib in patients with MTAP-del GEOPOLITICS | Oct 16, 2026, 11:03 AM UTC